Lincoln Pharmaceuticals (BOM:531633) Enterprise Value : ₹9,276 Mil (As of May. 08, 2025)

Lincoln Pharmaceuticals Enterprise Value Chart

Lincoln Pharmaceuticals Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
Enterprise Value		Get a 7-Day Free Trial					2,265.85	3,578.10	5,096.34	5,665.94	10,211.77

Lincoln Pharmaceuticals Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Enterprise Value	Get a 7-Day Free Trial															12,201.27	10,211.77	12,262.37	11,425.62	15,768.62

Competitive Comparison of Lincoln Pharmaceuticals's Enterprise Value

For the Drug Manufacturers - Specialty & Generic subindustry, Lincoln Pharmaceuticals's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Lincoln Pharmaceuticals's Enterprise Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lincoln Pharmaceuticals's Enterprise Value distribution charts can be found below:

* The bar in red indicates where Lincoln Pharmaceuticals's Enterprise Value falls into.

Lincoln Pharmaceuticals Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

Lincoln Pharmaceuticals's Enterprise Value for the fiscal year that ended in Mar. 2024 is calculated as

Lincoln Pharmaceuticals's Enterprise Value for the quarter that ended in Dec. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lincoln Pharmaceuticals  (BOM:531633) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

Lincoln Pharmaceuticals's EV-to-EBIT for today is

Lincoln Pharmaceuticals's current Enterprise Value is ₹9,276 Mil.
Lincoln Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,167 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

Lincoln Pharmaceuticals's EV-to-EBITDA for today is:

Lincoln Pharmaceuticals's current Enterprise Value is ₹9,276 Mil.
Lincoln Pharmaceuticals's EBITDA for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹1,290 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

Lincoln Pharmaceuticals's EV-to-Revenue for today is:

Lincoln Pharmaceuticals's current Enterprise Value is ₹9,276 Mil.
Lincoln Pharmaceuticals's Revenue for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹5,882 Mil.

4. EV-to-FCF is calculated as Enterprise Value divided by its Free Cash Flow.

Lincoln Pharmaceuticals's EV-to-FCF for today is:

Lincoln Pharmaceuticals's current Enterprise Value is ₹9,276 Mil.
Lincoln Pharmaceuticals's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lincoln Pharmaceuticals Enterprise Value Related Terms

Thank you for viewing the detailed overview of Lincoln Pharmaceuticals's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Lincoln Pharmaceuticals Business Description